Navigation Links
Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research
Date:11/11/2009

PARSIPPANY, N.J., Nov. 11 /PRNewswire/ -- Pharma market research thought leaders are discovering new ways to take advantage of the tremendous developments and opportunities in the pharmaceutical industry. The last twelve months has shown that no industry is insulated from tumultuous change. Pharmaceutical market research is no exception. But those who are able to make sense of the cacophony of information today will certainly rise to be the new leaders of tomorrow. The challenge is to be part of that elite group who has a firm grasp of what's happening and knows how to see through the trends and formulate concrete business solutions.

To tie all this critical information together, you can painstakingly seek out many sources ... or, easily go to one place. The 2010 Pharma Market Research Conference is the premier gathering of senior level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research. This unparalleled two-day industry event offers participants the unique opportunity to learn about what's going on in the industry to get ahead of the competition. To further enrich the 2010 Pharma Market Research Conference, there are also unparalleled networking opportunities, as well as educational sessions that are interactive and dynamic.

A few of the topics include:

Pharma Survival Game; Leveraging Market Research for Forecasting; Bringing Your Research Alive and Achieving a More Cost Effective Result; Segmentation; Market Research in the Biopharma Industry - Trends in 2010; Role of Market Research in Evolving Next Generation Bio-Pharma; Greening Market Research; Product Positioning Using Feature-Benefit-Value Segmentation; How to Design and Execute Market Research for Senior Decision Makers; Market Research in Asia

The distinguished speaking faculty come with in-depth knowledge and real-world experience from world-class pharma companies like Abbott, Alcon, AstraZeneca, Bayer, Biovail, Bristol-Myers Squibb, Daiichi Sankyo, Eisai, Forest Laboratories, Ironwood Pharmaceuticals, Johnson & Johnson, Lundbeck, Merck, Nicox, Pfizer, Regeneron Pharmaceuticals, Sanofi-Aventis, Shire, Thermo Fisher Scientific, and Wyeth.

Sponsors/exhibitors include Ipsos, KGC, MDLinx, MedPredict, Optimal Strategix Group, Panel Intelligence, PharmaForce, and Segmedica.

The 2010 Pharma Market Research Conference will be held on February 1-2, 2010 at the Sheraton Parsippany Hotel in Parsippany, New Jersey. If you'd like to register or view the agenda, visit www.pharmamarketresearchconference.com. Time you spend at the 2010 Pharma Market Research Conference is the best way to maximize your future success in the pharmaceutical industry.

    Amy Yueh
    Pharma Market Research Conference
    info@pharmamarketresearchconference.com
    +1 212 228 7974
    http://www.pharmamarketresearchconference.com

SOURCE Pharma Market Research Conference


'/>"/>
SOURCE Pharma Market Research Conference
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
2. Industry Executives Finding Value in Shift of Scientific Publications
3. New Survey Reveals Even After 12 Years of Living With Depression Adults Still Struggle Due to Lack of Basic Information
4. New Fall Allergy Capitals(TM) Reveal the Most Challenging Cities for Allergy Sufferers
5. NASA Research Reveals Major Insight Into Evolution of Life on Earth
6. Northern California Cancer Centers First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival
7. New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed
8. New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients
9. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
10. Ancestry.com DNA Testing Reveals Roots Authors Scottish Ancestry
11. New Research Reveals Unforeseen Side Effect of the Breast Cancer Movement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):